ArticleNature communications2026
Recurrent evolution of ligand-binding domain multiplicity fine-tunes TGFβ signaling in vertebrates.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
From sponges to mammals, TGFβ signalling is a central regulator of body plan, cell fate and tissue homeostasis, with receptor architecture highly conserved across metazoans. Here we identify unexpected evolutionary divergence within a key receptor structure: 12 independent ligand-binding domain (LBD) duplications across three receptor classes (ACVR1, BMPR2 and TGFBR2) in diverse vertebrate lineages, including fish, amphibians, birds, and mammals. These duplications reveal previously unrecognized structural and functional plasticity arising from domain-level innovation, including in established model organisms such as zebrafish, African clawed frog and chicken. Recently diverged lineages conserve the membrane-distal LBD and ligand-interacting residues, correlating with enhanced ligand binding, whereas more ancient lineages exhibit elevated evolutionary rates of the membrane-distal LBD associated with inhibitory function. Our findings reveal LBD multimerization as a recurring, lineage-independent mechanism that diversifies and fine-tunes TGFβ signalling, adding a regulatory dimension to one of the best-examined conserved and essential pathways in metazoan biology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.